Skip to content

DIAMIND: Diabetes SMS text reminders for women who have had gestational diabetes mellitus to test for type 2 diabetes or impaired glucose tolerance in the postpartum period

Diabetes SMS text reminders versus standard care for women who have had gestational diabetes mellitus to increase the rate of oral glucose tolerance testing in the postpartum period

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ANZCTR
Registry ID
ACTRN12612000621819
Acronym
DIAMIND
Enrollment
252
Registered
2012-06-08
Start date
2012-06-22
Completion date
2014-01-20
Last updated
2020-01-13

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None listed

Brief summary

Gestational diabetes is a form of diabetes, or glucose intolerance, that develops during pregnancy. Women who have had gestational diabetes are many times more likely to develop type 2 diabetes in the future compared with women who have normal blood glucose levels during pregnancy. Thus, it is important to screen these women after they have given birth to see whether they have type 2 diabetes, such that it can be treated, or to see whether they are on the way to developing type 2 diabetes (have impaired glucose tolerance), such that preventative changes can be made. The best way of detecting type 2 diabetes and impaired glucose tolerance is with an oral glucose tolerance test, and this test is recommended by many health organisations, such as the Australasian Diabetes in Pregnancy Society, to be undertaken in the early postpartum period. Despite this, evidence shows that many women who have had gestational diabetes do not receive this follow up testing. The DIAMIND study is aiming to test whether a text message based reminder system (using mobile phone technology) will increase the number of women who have had gestational diabetes who undertake oral glucose tolerance testing in the postpartum period.

Interventions

Intervention group = 6 week reminder. The intervention will consist of text message reminders sent to the participant's phone at 6 weeks postpartum, with a subsequent reminder at 3 months and 6 months if the participant does not report having undertaken an oral glucose tolerance test. The text messages will include the participant's first name, but will otherwise be generic. The text message will remind the participant that it is time for them to have an oral glucose tolerance test to see wheth

Intervention group = 6 week reminder. The intervention will consist of text message reminders sent to the participant's phone at 6 weeks postpartum, with a subsequent reminder at 3 months and 6 months if the participant does not report having undertaken an oral glucose tolerance test. The text messages will include the participant's first name, but will otherwise be generic. The text message will remind the participant that it is time for them to have an oral glucose tolerance test to see whether they have type 2 diabetes or impaired glucose tolerance. We also ask the participants to let us know when they have had the test, and the results of the test, although this part of the text message is for data collection purposes only.

Sponsors

Women's and Children's Hospital
Lead SponsorHospital

Study design

Allocation
Randomised controlled trial
Intervention model
Parallel
Primary purpose
Diagnosis
Masking
Blinded (masking used)

Eligibility

Sex/Gender
All
Age
0 to No maximum
Healthy volunteers
No

Inclusion criteria

(a) Diagnosed with GDM in this pregnancy (b) Access to a mobile phone (c) Postnatal blood glucose level returned to normal before discharge (d) Singleton or twin pregnancy

Exclusion criteria

(a) Known (pre-existing) type 1 or type 2 diabetes mellitus (b) Interpreter required (c) Stillbirth

Outcome results

None listed

Source: ANZCTR · Data processed: Mar 23, 2026